Sath Shukla - Net Worth and Insider Trading
Sath Shukla Net Worth
The estimated net worth of Sath Shukla is at least $1 Million dollars as of 2024-11-29. Sath Shukla is the CEO & President of Spero Therapeutics Inc and owns about 1,140,809 shares of Spero Therapeutics Inc (SPRO) stock worth over $1 Million. Details can be seen in Sath Shukla's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sath Shukla has not made any transactions after 2024-08-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sath Shukla
Sath Shukla Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sath Shukla owns 2 companies in total, including Alaunos Therapeutics Inc (TCRT) , and Spero Therapeutics Inc (SPRO) .
Click here to see the complete history of Sath Shukla’s form 4 insider trades.
Insider Ownership Summary of Sath Shukla
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCRT | Alaunos Therapeutics Inc | 2019-07-22 | EVP & Chief Financial Officer |
| SPRO | Spero Therapeutics Inc | 2024-08-27 | Chief Financial Officer |
Sath Shukla Latest Holdings Summary
Sath Shukla currently owns a total of 1 stock. Sath Shukla owns 1,140,809 shares of Spero Therapeutics Inc (SPRO) as of August 27, 2024, with a value of $1 Million.
Latest Holdings of Sath Shukla
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SPRO | Spero Therapeutics Inc | 2024-08-27 | 1,140,809 | 1.13 | 1,289,114 |
Holding Weightings of Sath Shukla
Sath Shukla Form 4 Trading Tracker
According to the SEC Form 4 filings, Sath Shukla has made a total of 6 transactions in Spero Therapeutics Inc (SPRO) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Spero Therapeutics Inc is the sale of 2,757 shares on August 27, 2024, which brought Sath Shukla around $3,722.
Insider Trading History of Sath Shukla
- 1
Sath Shukla Trading Performance
Sath Shukla Ownership Network
Sath Shukla Owned Company Details
What does Alaunos Therapeutics Inc do?
Who are the key executives at Alaunos Therapeutics Inc?
Sath Shukla is the EVP & Chief Financial Officer of Alaunos Therapeutics Inc. Other key executives at Alaunos Therapeutics Inc include director & Chief Executive Officer Boyle Kevin S. Sr. , VP & Finance Michael Wong , and See Remarks Abhishek K Srivastava .
Alaunos Therapeutics Inc (TCRT) Insider Trades Summary
Over the past 18 months, Sath Shukla made no insider transaction in Alaunos Therapeutics Inc (TCRT). Other recent insider transactions involving Alaunos Therapeutics Inc (TCRT) include a net sale of 68,014 shares made by Boyle Kevin S. Sr. ,
In summary, during the past 3 months, insiders sold 0 shares of Alaunos Therapeutics Inc (TCRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 453 shares of Alaunos Therapeutics Inc (TCRT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 453 shares.
Alaunos Therapeutics Inc (TCRT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alaunos Therapeutics Inc Insider Transactions
Sath Shukla Mailing Address
Above is the net worth, insider trading, and ownership report for Sath Shukla. You might contact Sath Shukla via mailing address: C/o Ziopharm Oncology, Inc., One First Avenue, Parris Building #34, Boston Ma 02129.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
